BMJ Oncology
@BMJOncology
A new #OA journal from @bmj_company publishing across the broad spectrum of cancer research, investigation, treatment & practice. EIC: Prof Ananya Choudhury
What better time to launch a new journal? 🎉 Welcome to BMJ Oncology - we will capture the breadth of translational medicine, clinical endeavour, policy and opinion across the whole specialty. bmjoncology.bmj.com/content/1/1/e0… @PharmKristoffer @achoud72
Just as democracy depends on a free and independent press to hold power accountable, medical progress depends on independent journals to vet, challenge and advance science without political interference. washingtonpost.com/opinions/2025/…
📣 Elucidating the mechanisms of lifestyle interventions in mitigating radiotherapy adverse effects: a scoping review Read the new review from @AmyHarwood91 @achoud72 and colleagues in BMJ Oncology now:

Generative artificial intelligence is becoming increasingly embedded in how today’s medical students learn and practise medicine. But should it be formally taught within the medical curriculum? bmj.com/content/390/bm…
This study supports expanding risk-reducing mastectomy access beyond the traditional pathogenic variant carriers like BRCA1, BRCA2, and PALB2. jamanetwork.com/journals/jamao…
In 3 prospective cohorts comprised of 2.2 million individuals from UK and China, #Diabetes increases the risk of #LiverCancer #PancreaticCancer #BladderCancer New @JNCI_Now study: academic.oup.com/jnci/advance-a…
Patients receiving adjuvant trastuzumab for early HER2 positive breast cancer could receive 6 months rather than 12 months treatment. bmjoncology.bmj.com/content/4/1/e0…
This new #OriginalResearch from Matthew E Barclay and colleagues extended previous evidence on international variation in the use of the two principal non-surgical treatments in patients with lung cancer, by additionally stratifying analyses by age-stage and sex-stage groups, and…

mRNA cancer vaccines show early promise against challenging malignancies, such as glioblastoma, pancreatic cancer, and advanced melanoma. However, US researchers worry that funding cuts and changing regulatory priorities could impede progress. thelancet.com/journals/lanon…
This study compares outcomes between intravenous and oral administration of chemotherapy in patients with nasopharyngeal carcinoma. bmjoncology.bmj.com/content/4/1/e0…
In a retrospective cohort study among persons with cancer in the US, COVID-19 boosters reduced hospitalizations by 29%. @JAMAOnc jamanetwork.com/journals/jamao…
This review provides insights into the advantages and limitations of ctDNA cancer detection strategies that can help improve clinical care for patients. academic.oup.com/oncolo/advance…
Four social determinants of health should be assessed for all patients presenting for cancer care: (1) transportation access, (2) housing security, (3) access to food, and (4) financial security. jnccn.org/view/journals/…
cfDNA testing could have a beneficial role to improve colorectal cancer screening outcomes if it improves patient uptake of screening but would have little impact if utilization remained the same jamanetwork.com/journals/jamao…
Twenty years of working in medicine is just long enough to realise how much things change and how little the core truths ever will. Patients still seek empathy, doctors still grapple with uncertainty, and illness remains stubbornly indifferent bmj.com/content/390/bm…
Metformin, a commonly prescribed and widely used medication, has gained considerable interest for its favourable metabolic effects and anti-neoplastic effect. thelancet.com/journals/lanon…
There is substantial variability in the use of chemotherapy and radiotherapy for patients with lung cancer. bmjoncology.bmj.com/content/4/1/e0…

Despite its efficacy, RT is accompanied by a spectrum of adverse effects that can significantly impact patients’ quality of life. In light of this, there arises a need to explore complementary strategies that can attenuate these adverse effects. bmjoncology.bmj.com/content/4/1/e0…
This review serves as a non-technical primer for clinicians to understand, evaluate, and participate as active users in large language model technologies. bmjoncology.bmj.com/content/4/1/e0…

This narrative review serves as a non-technical primer for clinicians to understand, evaluate, and participate as active users in large language model technologies bmjoncology.bmj.com/content/4/1/e0…
📢 Our companion title, BMJ Connections Oncology, has published its first research article! Read the full paper on the association between #immunecheckpointinhibitor treatment and hospitalisation risk after #COVID19 infection. connectionsoncology.bmj.com/content/2/1/e0… @UAlberta_DoM @AbSPORU